Latest news with #AgilentTechnologies
Yahoo
21 hours ago
- Business
- Yahoo
Here's How Much You'd Have If You Invested $1000 in Agilent Technologies a Decade Ago
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in investing, especially with particular tech giants, as well as popular consumer-facing stocks. What if you'd invested in Agilent Technologies (A) ten years ago? It may not have been easy to hold on to A for all that time, but if you did, how much would your investment be worth today? With that in mind, let's take a look at Agilent Technologies' main business drivers. Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end the last three years, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as reported revenues of $6.51 billion in fiscal 2024. The company generated 39.5% of revenues from Americas, 27.2% from Europe and 33.2% from Asia-Pacific region in the fiscal accounted for 49.3% of fiscal 2024 revenues, DGG contributed 25.4% and ACG represented the remaining 25.3%.Most of the competition for these three segments comes from Bruker Corp., Danaher Corp, Affymetrix, GE Healthcare, Life Technologies Corp., Thermo Fisher Scientific, Waters Corp., Illumina, Inc., Life Technologies Corp., Abbott Laboratories, Sakura, Roche, Perkin Elmer Corp., Shimadzu Corp, Heidenhain Corp., Malvern Instruments, Seiko Instruments, Veeco Instruments and Zygo first-quarter fiscal 2025, Agilent announced a change in its operating segments to move cell analysis business from life sciences and applied markets segment to its diagnostics and genomics operating segment. The new structure includes the Life Sciences and Diagnostics Markets Group (LDG), Applied Markets Group (AMG) and Agilent Cross Lab Group (ACG). While anyone can invest, building a lucrative investment portfolio takes research, patience, and a little bit of risk. If you had invested in Agilent Technologies ten years ago, you're probably feeling pretty good about your investment today. According to our calculations, a $1000 investment made in June 2015 would be worth $2,895.24, or a gain of 189.52%, as of June 19, 2025, and this return excludes dividends but includes price increases. In comparison, the S&P 500 gained 181.95% and the price of gold went up 169.51% over the same time frame. Going forward, analysts are expecting more upside for A. Agilent is benefiting from strength in the Agilent Cross Lab Group segment, owing to solid lab demand and growing momentum in the CrossLab team. Infinity III is gaining adoption, driven by advanced automation. Improving the capital expenditure spending rate is expected to benefit Agilent's prospects. The company benefited from continued momentum in its core end markets, including pharmaceuticals, diagnostics, and food, while also seeing recovery in biopharma and emerging opportunities in environmental testing. It targets to grow core revenues between 5% and 7% annually, expand operating margin by 50 to 100 basis points per year, and deliver double-digit earnings growth. However, the company is suffering from a challenging macroeconomic environment and tariffs and headwinds in China. Unfavorable forex is a headwind. Shares have gained 6.07% over the past four weeks and there have been 4 higher earnings estimate revisions for fiscal 2025 compared to none lower. The consensus estimate has moved up as well. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Globe and Mail
2 days ago
- Business
- Globe and Mail
Peptide Synthesis Market to Hit USD 1.41 Billion by 2029 with 11.7% CAGR
"Thermo Fisher Scientific Inc. is one of the dominant players in the peptide synthesis market. The company's leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of various growth strategies." The market for peptide synthesis market is competitive, with key players strategizing to capture the majority market share. Prominent players in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Kaneka Corporation (Japan), GenScript (China) The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in 2024 and an impressive US$ 1.41 Billion by 2029. The peptide synthesis market is driven by the growing demand for therapeutic peptides in treating chronic diseases, including cancer, diabetes, and cardiovascular disorders. Advancements in solid-phase peptide synthesis (SPPS) and hybrid approaches have significantly improved efficiency, yield, and cost-effectiveness, fueling adoption in pharmaceutical R&D. The rise of personalized medicine has further expanded the need for custom peptide synthesis, supporting applications in targeted therapies and biomarker research. Emerging trends such as the integration of automation and AI-driven platforms among the instruments is further likely to fuel the market growth in coming years. Browse in-depth TOC on " Peptide Synthesis Market" 513 - Tables 55 - Figures 460 - Pages Based on offerings, the market is segmented into products and services. By-products market is further divided into consumables and instruments. Among these consumables dominated the peptide synthesis market. The consumables segment is further bifurcated into reagents and other consumables. The reagents market is further divided into resins, amino acids, coupling reagents, dyes & fluorescent labeling reagents, deprotection agents, cleavage reagents, and other reagents. In 2023, the resins segment accounted for the largest share of the peptide synthesis market. Resins play an important role in solid-phase peptide synthesis (SPPS), the most widely used method for peptide production. For instance, polystyrene-based and PEG-based resins are extensively used due to their high stability and scalability. The instruments segment is further divided into peptide synthesizers, chromatography equipment, lyophilizers, and others. The peptide synthesizer segment is further divided into automated and manual peptide synthesizers. Peptide synthesizers dominated the instruments market due to their ability to automate and streamline peptide production, making them essential for research and industrial applications. The growing demand for custom peptides in drug discovery, diagnostic research, and therapeutic applications has further boosted the adoption of advanced synthesizers. The services segment is further divided into peptide library synthesis, peptide synthesis, peptide purification services, and peptide analysis services. The peptide synthesis segment dominated the services segment. The increasing adoption of peptides in emerging fields such as personalized medicine, vaccine development, and epigenetics drives demand for custom synthesis solutions, fostering growth in the segment. Based on technique, the peptide synthesis market is segmented into chemical and biological. The chemical segment is further divided into solid-phase peptide synthesis, solution-phase peptide synthesis, and others. The biological segment is divided into recombinant DNA technology and enzymes. The chemical segment dominated the market in 2023. The solid-phase peptide synthesis (SPPS) segment dominates the peptide synthesis market due to its efficiency, scalability, and widespread adoption in research and commercial applications. The dominance of SPPS is further driven by advancements in automation and reagent technologies, which have significantly reduced synthesis time and enhanced yield. Based on application, the market is divided into therapeutics, diagnostics, and research & development. Therapeutics by indication is further divided into cancer, diabetes, obesity, autoimmune disease, and other disease indications. Therapeutics by molecules is further segmented into peptide-based vaccines, peptide-drug conjugates (PDCs), peptide inhibitors, and other molecules. Therapeutic applications dominated the peptide synthesis market due to the growing demand for peptide-based drugs, which offer targeted and effective treatments with fewer side effects compared to traditional small molecules. The peptide synthesis market is segmented by end users into pharmaceutical and biotechnology companies, CDMOS & CROS, academic and research institutes, medical device companies, and hospitals and diagnostic centers. The pharmaceutical and biotechnology companies segment held the largest market share in 2023. The rise of peptide-based drugs and biologics has led to increased investments by pharmaceutical and biotech firms in peptide synthesis technologies, particularly in the production of therapeutic peptides for diseases such as cancer, diabetes, and autoimmune disorders. These factors are fueling the growth of the segment. The market is segmented by region into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America dominated the peptide synthesis market in 2023, and the Asia Pacific region is likely to grow at a significant CAGR during the forecast period. US-dominated North American peptide synthesis market owing to the presence of strong pharmaceutical and biotechnology companies in the country, advanced research infrastructure, and significant investments in drug discovery and development. The Asia Pacific region is anticipated to grow at a significant CAGR due to growing focus on personalized medicine and peptide-based therapeutics in the region fuels the demand for advanced peptide synthesis technologies. The market for peptide synthesis market is competitive, with key players strategizing to capture the majority market share. Prominent players in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Kaneka Corporation (Japan), GenScript (China), and Bachem Holding AG (Switzerland), among others. The market players have adopted various organic and inorganic growth strategies, such as the development of advanced products, partnerships, agreements, expansions, and acquisitions to strengthen their position in the peptide synthesis market. Thermo Fisher Scientific Inc. is one of the dominant players in the peptide synthesis market. The company's leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of various growth strategies. The company offers a wide range of peptide synthesis products and services. The company has adopted different growth strategies, such as deals that include agreements, and acquisitions, to maintain its leading position in the peptide synthesis market. The company's strong customer support and extensive distribution network further solidify the company's leadership position in the market. Merck KGaA is a key player in the peptide synthesis market, leveraging its expertise in life sciences and advanced chemical technologies. The company's Novabiochem product line offers a broad range of high-quality reagents, resins, and building blocks essential for efficient and reliable peptide synthesis. Merck KGaA focuses on innovation supporting advanced techniques such as microwave-assisted synthesis, which significantly improves reaction efficiency and yield. The company's strategic partnerships and increased investments in biopharmaceutical R&D further enhance its competitive edge in the market. Merck's strong geographic presence and adoption of growth strategies further contribute to its dominance in the market. For more information, Inquire Now!
Yahoo
7 days ago
- Business
- Yahoo
Gas Chromatography Market Set to Reach USD 5.47 Billion by 2032, Driven by Growing Demand Across Pharmaceuticals and Environmental Testing Applications
SNS Insider Unveils Strategic Insights into the U.S. Gas Chromatography Market's Rising Trajectory—Worth USD 1.13 Billion in 2023—As Regulatory Pressures and Advanced Analytical Needs Drive Innovation Across Biotech and Environmental Labs Ausrin, June 13, 2025 (GLOBE NEWSWIRE) -- Gas Chromatography Market Size & Growth Analysis: According to SNS Insider, the Gas Chromatography Market was valued at USD 3.48 billion in 2023 and is projected to reach USD 5.47 billion by 2032, growing at a CAGR of 5.16% during the forecast period of 2024–2032. The market is experiencing strong demand due to increasing utilization in environmental monitoring, drug discovery, forensic sciences, and food safety applications. The ongoing evolution of GC systems and the overall trend toward precision analytical testing across various industries are key factors propelling the expansion of the a Sample Report of Gas Chromatography Market@ In the US, the gas chromatography market was valued at approximately USD 1.13 billion in 2023 and is projected to reach USD 1.76 billion by 2032, growing at a CAGR of 5.05%. The market is mainly propelled by the strong pharmaceutical sector, as well as the regulatory pressure to control pollution and increasing R&D activities within the biotech and environmental laboratories in the United States. Market Overview Gas chromatography (GC) is a fundamental analytical tool in multiple industries such as healthcare, energy, food and beverage, forensics, and environmental monitoring. Due to the increasing interest in environmental pollution and food safety, the ability of GC to identify and quantify chemical compounds is increasingly acknowledged. It is sensitive, rapid, and accurate—making it the method of choice in research and commercial laboratories. Furthermore, trends towards miniaturization and automation have resulted in the growing application of portable GC systems, thereby improving accessibility and efficiency. Moreover, green energy campaigns and carbon-neutral targets have further spurred the need for accurate gas composition analyses. GC is now commonly used for the monitoring of greenhouse gases, hydrogen purity, and biogas composition, particularly in nations promoting sustainable energy. Along with the increasing use in anti-doping and forensic toxicology, the market is expected to continue growing steadily over the coming years. Major Players Analysis Listed in this Report are: Agilent Technologies, Inc. – 7890B GC System, Intuvo 9000 GC System Thermo Fisher Scientific, Inc– TRACE 1600 Series GC, AI/AS 1610 Autosampler Shimadzu Corporation– Nexis GC-2030, GC-2014 PerkinElmer, Inc. – Clarus 590, Clarus 690 Restek Corporation– Rtx Columns, Super Clean Gas Filters Dani Instruments S.P.A. – Master GC, Master TOF-MS Chromatotec – AirmoVOC, ChromaFID Merck KGAA – Supelco GC Columns, GC Accessories Leco Corporation – Pegasus BT GC-TOFMS, GCxGC Systems Scion Instruments – SCION 456-GC, SCION 8700 SQ GC-MS Phenomenex – Zebron GC Columns, Strata-X SPE Cartridges GL Sciences – GC-4000, InertCap GC Columns OI Analytical – 5383 Pulsed Flame Photometric Detector, 5360X Halogen Specific Detector Valco Company Instruments Inc. – Valco Valves, GC Sample Loops Centurion Scientific – GC Accessories, Gas Purifiers SRI Instruments – Model 8610C GC, Model 310 GC Skyray Instruments – GC-6800, GC-4500 E ChromTech Co. Ltd. – CT-GC8000, CT-GC9000 Trajan Scientific – SGE Syringes, BPX GC Columns Falcon Analytical – CALIDUS Ultrafast GC, UltraFast Mass Spec Gas Chromatography Market Report Scope Report Attributes Details Market Size in 2023 USD 3.48 billion Market Size by 2032 USD 5.47 billion CAGR (2024–2032) 5.16% U.S. Market 2023 USD 1.13 billion U.S. Forecast by 2032 USD 1.76 billion Base Year 2023 Forecast Period 2024–2032 Key Regional Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis By Product: Among the products, reagents were the most lucrative segment, generating 57.7% of total market revenue in 2023. Their functions in sample preparation, ease of use and reliable separations mean they are critical tools for virtually any GC analysis. Increasing applications of chromatography in food and pharmaceutical testing is also increasing the demand for reagents. The accessories and consumables segment, on the other hand, is anticipated to register the highest CAGR throughout the forecast period. This can be attributed to increasing need for maintenance and replacement of components such as syringes, septa, liners, and detector parts. Continuous usage of analytical labs causes wear and tear, resulting in repurchases and rising revenues for this category. By End-use: End users such as pharmaceutical and biotechnology companies held the largest share of the GC market revenue in 2023. This market is primarily dependent on GC for quality control, regulatory compliance and active pharmaceutical ingredient (API) analysis. It is frequently used due to the need for highly accurate quantification in drug development and clinical trials. Meanwhile, this end-use segment is evaluated to witness the fastest growth rate over the forecast timeframe. Increasing biopharmaceutical research activities, stringent FDA regulations, and rising investment in the field of biologics and biosimilars are fueling the use of gas chromatography in pharmaceutical and biotech companies, which is the fastest-growing application segment. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Gas Chromatography Market Segmentation By Product Accessories & Consumables Fittings and tubing Auto-sampler accessories Flow management and pressure regulator accessories Others Instruments Systems Auto-samplers Fraction collectors Detectors Reagents Analytical gas chromatography reagents Bioprocess gas chromatography reagents By End-User Pharmaceutical & Biotechnology Company Academic & Research Institutes Food and Beverage Others(oil & Gas) Regional Analysis North America was the largest revenue contributor, accounting for 43.2% share of the global gas chromatography market in 2023. The strength of the area is thought to be due to a strong health care system, an established pharmaceutical and food industry, and strict environmental rules. Strong market presence of key players and well-established R&D infrastructure support the growth of the market in the US & Canada. On the other hand, the Asia-Pacific region is anticipated to grow at the highest rate through 2024. Owing to the rapid process of industrialization, rising government efforts toward pollution control, and a surge in pharmaceutical production, especially in China and India. Moreover, increasing attention to food quality and safety from regional testing laboratories is compelling the integration of GC into the testing environment. Recent Developments In January 2025, Shimadzu Corporation introduced seven new GC systems, including Brevis GC-2050, which is compact and developed with a focus on enhancing sustainability and energy efficiency in line with green energy programs. In May 2024, Agilent Technologies opened its newly designed Gas Chromatography Systems Manufacturing facility in Cedar Creek, Texas, at the Austin Community Park, which will enable the company to meet rapidly growing global demand for analytical instruments and address the greater range of products to be made at the plant. In September 2023, Thermo Fisher Scientific is commercially releasing the new TRACE 1600 Series GC systems featuring intelligent analytical technology and software advancements that enable laboratories to realize increased productivity from their current assets. Buy a Single-User PDF of Gas Chromatography Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Gas Chromatography Market by Product 8. Gas Chromatography Market by End-Use 9. Regional Analysis 10. Company Profiles 11. Use Cases and Best Practices 12. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 days ago
- Business
- Yahoo
Gas Chromatography Market Set to Reach USD 5.47 Billion by 2032, Driven by Growing Demand Across Pharmaceuticals and Environmental Testing Applications
SNS Insider Unveils Strategic Insights into the U.S. Gas Chromatography Market's Rising Trajectory—Worth USD 1.13 Billion in 2023—As Regulatory Pressures and Advanced Analytical Needs Drive Innovation Across Biotech and Environmental Labs Ausrin, June 13, 2025 (GLOBE NEWSWIRE) -- Gas Chromatography Market Size & Growth Analysis: According to SNS Insider, the Gas Chromatography Market was valued at USD 3.48 billion in 2023 and is projected to reach USD 5.47 billion by 2032, growing at a CAGR of 5.16% during the forecast period of 2024–2032. The market is experiencing strong demand due to increasing utilization in environmental monitoring, drug discovery, forensic sciences, and food safety applications. The ongoing evolution of GC systems and the overall trend toward precision analytical testing across various industries are key factors propelling the expansion of the a Sample Report of Gas Chromatography Market@ In the US, the gas chromatography market was valued at approximately USD 1.13 billion in 2023 and is projected to reach USD 1.76 billion by 2032, growing at a CAGR of 5.05%. The market is mainly propelled by the strong pharmaceutical sector, as well as the regulatory pressure to control pollution and increasing R&D activities within the biotech and environmental laboratories in the United States. Market Overview Gas chromatography (GC) is a fundamental analytical tool in multiple industries such as healthcare, energy, food and beverage, forensics, and environmental monitoring. Due to the increasing interest in environmental pollution and food safety, the ability of GC to identify and quantify chemical compounds is increasingly acknowledged. It is sensitive, rapid, and accurate—making it the method of choice in research and commercial laboratories. Furthermore, trends towards miniaturization and automation have resulted in the growing application of portable GC systems, thereby improving accessibility and efficiency. Moreover, green energy campaigns and carbon-neutral targets have further spurred the need for accurate gas composition analyses. GC is now commonly used for the monitoring of greenhouse gases, hydrogen purity, and biogas composition, particularly in nations promoting sustainable energy. Along with the increasing use in anti-doping and forensic toxicology, the market is expected to continue growing steadily over the coming years. Major Players Analysis Listed in this Report are: Agilent Technologies, Inc. – 7890B GC System, Intuvo 9000 GC System Thermo Fisher Scientific, Inc– TRACE 1600 Series GC, AI/AS 1610 Autosampler Shimadzu Corporation– Nexis GC-2030, GC-2014 PerkinElmer, Inc. – Clarus 590, Clarus 690 Restek Corporation– Rtx Columns, Super Clean Gas Filters Dani Instruments S.P.A. – Master GC, Master TOF-MS Chromatotec – AirmoVOC, ChromaFID Merck KGAA – Supelco GC Columns, GC Accessories Leco Corporation – Pegasus BT GC-TOFMS, GCxGC Systems Scion Instruments – SCION 456-GC, SCION 8700 SQ GC-MS Phenomenex – Zebron GC Columns, Strata-X SPE Cartridges GL Sciences – GC-4000, InertCap GC Columns OI Analytical – 5383 Pulsed Flame Photometric Detector, 5360X Halogen Specific Detector Valco Company Instruments Inc. – Valco Valves, GC Sample Loops Centurion Scientific – GC Accessories, Gas Purifiers SRI Instruments – Model 8610C GC, Model 310 GC Skyray Instruments – GC-6800, GC-4500 E ChromTech Co. Ltd. – CT-GC8000, CT-GC9000 Trajan Scientific – SGE Syringes, BPX GC Columns Falcon Analytical – CALIDUS Ultrafast GC, UltraFast Mass Spec Gas Chromatography Market Report Scope Report Attributes Details Market Size in 2023 USD 3.48 billion Market Size by 2032 USD 5.47 billion CAGR (2024–2032) 5.16% U.S. Market 2023 USD 1.13 billion U.S. Forecast by 2032 USD 1.76 billion Base Year 2023 Forecast Period 2024–2032 Key Regional Coverage North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) Segment Analysis By Product: Among the products, reagents were the most lucrative segment, generating 57.7% of total market revenue in 2023. Their functions in sample preparation, ease of use and reliable separations mean they are critical tools for virtually any GC analysis. Increasing applications of chromatography in food and pharmaceutical testing is also increasing the demand for reagents. The accessories and consumables segment, on the other hand, is anticipated to register the highest CAGR throughout the forecast period. This can be attributed to increasing need for maintenance and replacement of components such as syringes, septa, liners, and detector parts. Continuous usage of analytical labs causes wear and tear, resulting in repurchases and rising revenues for this category. By End-use: End users such as pharmaceutical and biotechnology companies held the largest share of the GC market revenue in 2023. This market is primarily dependent on GC for quality control, regulatory compliance and active pharmaceutical ingredient (API) analysis. It is frequently used due to the need for highly accurate quantification in drug development and clinical trials. Meanwhile, this end-use segment is evaluated to witness the fastest growth rate over the forecast timeframe. Increasing biopharmaceutical research activities, stringent FDA regulations, and rising investment in the field of biologics and biosimilars are fueling the use of gas chromatography in pharmaceutical and biotech companies, which is the fastest-growing application segment. For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ Gas Chromatography Market Segmentation By Product Accessories & Consumables Fittings and tubing Auto-sampler accessories Flow management and pressure regulator accessories Others Instruments Systems Auto-samplers Fraction collectors Detectors Reagents Analytical gas chromatography reagents Bioprocess gas chromatography reagents By End-User Pharmaceutical & Biotechnology Company Academic & Research Institutes Food and Beverage Others(oil & Gas) Regional Analysis North America was the largest revenue contributor, accounting for 43.2% share of the global gas chromatography market in 2023. The strength of the area is thought to be due to a strong health care system, an established pharmaceutical and food industry, and strict environmental rules. Strong market presence of key players and well-established R&D infrastructure support the growth of the market in the US & Canada. On the other hand, the Asia-Pacific region is anticipated to grow at the highest rate through 2024. Owing to the rapid process of industrialization, rising government efforts toward pollution control, and a surge in pharmaceutical production, especially in China and India. Moreover, increasing attention to food quality and safety from regional testing laboratories is compelling the integration of GC into the testing environment. Recent Developments In January 2025, Shimadzu Corporation introduced seven new GC systems, including Brevis GC-2050, which is compact and developed with a focus on enhancing sustainability and energy efficiency in line with green energy programs. In May 2024, Agilent Technologies opened its newly designed Gas Chromatography Systems Manufacturing facility in Cedar Creek, Texas, at the Austin Community Park, which will enable the company to meet rapidly growing global demand for analytical instruments and address the greater range of products to be made at the plant. In September 2023, Thermo Fisher Scientific is commercially releasing the new TRACE 1600 Series GC systems featuring intelligent analytical technology and software advancements that enable laboratories to realize increased productivity from their current assets. Buy a Single-User PDF of Gas Chromatography Market Analysis & Outlook Report 2024-2032@ Table of Contents – Major Key Points 1. Introduction 2. Executive Summary 3. Research Methodology 4. Market Dynamics Impact Analysis 5. Statistical Insights and Trends Reporting 6. Competitive Landscape 7. Gas Chromatography Market by Product 8. Gas Chromatography Market by End-Use 9. Regional Analysis 10. Company Profiles 11. Use Cases and Best Practices 12. Conclusion About Us: SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world. CONTACT: Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@ in to access your portfolio
Business Wire
10-06-2025
- Business
- Business Wire
Tagomics Awarded £860k Innovate UK Biomedical Catalyst Grant for Detection of Colorectal Cancer
CAMBRIDGE, England--(BUSINESS WIRE)--Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, today announced it has been awarded £860k Innovate UK funding as part of the Biomedical Catalyst programme for the testing and development of innovative healthcare solutions from Innovate UK, the UK's innovation agency, with the remaining funding contributed by Tagomics. The funding will support the customisation of Tagomics's Interlace TM platform to develop a highly sensitive and specific diagnostic test for the early detection and treatment of colorectal cancer, and subsequent pilot study with the NHS. Tagomics' Interlace platform is a novel multiomics workflow that unlocks disease-associated DNA biomarkers, leveraging a unique approach to epigenetic profiling which enriches unmethylated DNA for analysis without modifying the underlying DNA sequence. The Biomedical Catalyst grant will be used to apply Interlace to the detection of genetic and epigenetic mutations associated with colorectal cancer, including the development of new models for the analysis of patient multiomic profiles and identification of new disease biomarkers. A pilot study of the diagnostic test for the early detection of colorectal cancer in a clinical patient cohort will be led by Dr Arash Assadsangabi, Consultant physician and Gastroenterologist at Salford Royal NHS Foundation Trust, in collaboration with the Northern Care Alliance Research Collection biobank. The study will profile 250 patients suspected of having colorectal cancer to validate identified biomarkers and demonstrate the use of multiomic profiling for early detection of disease. Dr Robert Neely, CSO and co-founder of Tagomics said: 'We are delighted to have been awarded the Biomedical Catalyst grant as part of the Innovate UK programme, recognising the potential of our multiomic workflow in novel diagnostic and therapeutic technologies. We believe that the unique, information-rich dataset that Interlace provides us will be pivotal in detecting colorectal cancer at the earliest possible stages of development, enabling treatment of the cancer when it is most vulnerable to modern therapeutics, with the aim of dramatically improving patient outcomes.' Following successful completion of the project, Tagomics will further expand the capabilities and applications of Interlace with the support of Agilent Technologies, building on the Companies' established partnership that was key to the early development of the Interlace platform. Dr Rita Shaknovich, Chief Medical Officer at Agilent Technologies, commented: 'The Biomedical Catalyst grant is a fantastic achievement for Tagomics, reflecting the enormous potential for its novel multiomics workflow in the early detection of cancers. We look forward to continuing our collaboration with Tagomics and supporting the development of new applications for the Interlace platform, which brings together the strengths of Tagomics' epigenetics platform with Agilent's SureSelect target enrichment solutions, furthering cancer research and ultimately aiming to improve patient outcomes.'
